Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof

Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof

US Patent 10344092 · Granted Jul 9, 2019

Estimated economic value: $26,518,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD137 binding molecules and uses thereof2025
CD137 binding molecules and uses thereof2025
CD137 binding molecules and uses thereof2025
Document creation method and apparatus, and device and storage medium2025
Document editing method and apparatus, device, and storage medium2025
Multilayer light-filtering structure and fabricating method thereof2025
Organoids for drug screening and personalized medicine2025
Garlic extract and method thereof2025
Document processing method, apparatus and device, and medium2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
Fast creation of a second document associated with a first document2024
Apparatus and methods for high-speed drivers2024